0 New animal model first to mimic HIV infection in infants
Researchers have developed an animal model mimicking HIV infection in infants, potentially allowing the development of therapeutics and interventions for the pediatric population.
Browsing: Basic > Drug Development
0 First new oral and IV antibiotic with novel mechanism of action approved in nearly two decades
Xenleta™ (lefamulin), developed by Nabriva Therapeutics, has been approved by the US FDA for adults with community-acquired bacterial pneumonia, marking the first new antibiotic with a novel mechanism of action to be approved in nearly two decades.
0 Polio, picornaviruses and publicizing science – an interview with Vincent Racaniello
In this interview we speak to Vincent Racaniello, Professor of Microbiology & Immunology, about his work on polio, picornaviruses and publicizing science through blogs and podcasts.
0 US FDA approves Pretomanid tablets for drug-resistant tuberculosis
The US FDA has approved Pretomanid tablets in combination with bedaquiline and linezolid for the treatment of specific types of drug-resistant pulmonary tuberculosis.
1 Two Ebola treatments prove effective in DRC outbreak
A study of four Ebola therapeutics demonstrated that two drugs showed significantly improved survival rates, leading to the trial being halted early.
0 Coagulation factors show activity against drug-resistant Gram-negative bacteria
Coagulation factors, which normally function to clot blood, have been demonstrated to have antibacterial action against Gram-negative bacteria in vitro and in mouse models.
0 US FDA approves RECARBRIO™ for complicated UTIs and complicated intra-abdominal infections: July’s industry headlines
Take a look at this month’s industry headlines including a US FDA approval for RECARBRIO™, positive results for XOFLUZA in children and new ACIP recommendations.
0 IAS 2019: highlights and headlines
Find out more about the headlines from the 10th International AIDS Society Conference on HIV Science (IAS 2019) in our round-up of conference news.
0 Infographic: Gonorrhea – a timeline of resistance and it’s mechanisms
In this infographic we give you a visual snapshot of the antibiotics introduced for gonorrhea and a timeline of when resistance was first identified, in addition to setting out some of the primary resistance mechanisms.
0 Modulating arbovirus infection via mosquito saliva – an interview with Daniella Lefteri
In this interview we speak to Daniella Lefteri about her research on modulating arbovirus infection by targeting mosquito saliva, and what avenues this could present for new antiviral treatments.
